DNTRIPLED Medical Services - Moderne Apherese/Modern Apheresis/Nowoczesna Afereza is a private medical center located in Warsaw, Poland. We are the first private clinic in Poland to offer advanced therapeutic apheresis, including Double-Filtration Plasmapheresis (DFPP), LDL apheresis, and hemoperfusion. Procedures are carried out in accordance with recognized American and German apheresis guidelines, ensuring the highest standards of medical care. Our clinic utilizes state-of-the-art apheresis technology from Medica S.p.A. (Italy) together with sterile, single-use treatment sets. Each procedure is supervised by a doctor.
Therapeutic apheresis is a modern blood purification procedure in which disease-causing substances are targetedly removed from the blood using special filters or adsorption cartridges. The safety and effectiveness of apheresis are scientifically proven, recognized by medical professional societies worldwide, and described in apheresis standards for many diseases:
- Autoimmune diseases
- Chronic Fatigue Syndrome
- Long-COVID
- Hyperlipidemia
- Severe Alcohol Intoxication
- Pancreatitis, Hepatitis, Nephritis
- Vasculitis, Atherosclerosis, Myocarditis
- Dermatitis, Eczema, Psoriasis
- Lupus, Rheumatoid Arthritis
- Alzheimer’s Disease
- Myasthenia Gravis
- Demyelinating Diseases
- Allergies
- Multiple Sclerosis
1. Double Filtration Plasmapheresis (DFPP)
Blood flows through a
filter that separates the plasma from the blood cells, including red blood
cells, and these cells are returned to the patient's body right after
separation.
The separated plasma
then passes through a plasma fractionator filter containing a porous membrane.
Depending on the type of fractionator, the membrane can retain potentially
pathogenic particles, including autoantibodies, pathogenic immune complexes, inflammatory
mediators, lipoproteins, heavy metals, and certain toxins. The filtered plasma
is continuously returned to the patient's circulation. The plasma
fractionator is selected based on patient’s medical condition. Depending on the
underlying disease, the reduction of the abovementioned substances may
contribute to:
Selective blood purification: removal of autoantibodies, cytokines,
toxins and pathogenic immune complexes
Anti-inflammatory effect: relieves the immune system and limits
inflammatory processes
Body regeneration: support for natural repair processes and cell
function
Improved physical and mental fitness and anti-aging effect at the
cellular level.
Clinical effects depend on the
underlying disease and cannot be guaranteed.
2. LDL-Apheresis (low-density lipoprotein apheresis) using DFPP method
The purpose of LDL
apheresis is to temporarily reduce the concentration of LDL cholesterol,
triglycerides and lipoprotein(a) circulating in the blood.
Blood flows through a
filter that separates the plasma from the blood cells, including red blood
cells, and these cells are returned to the patient's body right after
separation. The separated plasma then passes through a plasma fractionator
filter containing a porous membrane. This filter selectively retains
low-density lipoproteins (LDL) and lipoprotein(a). The filtered plasma is continuously
returned to the patient's circulation.
LDL-Apheresis may
contribute to:
Reducing the concentration of atherogenic lipoproteins in the blood
Reducing the risk of acute pancreatitis in patients with severe
hypertriglyceridemia
Reducing inflammatory processes in vessels and stabilization of
atherosclerotic plaques
Slowing down the progression of atherosclerosis
Because the body
constantly produces lipoproteins, the resulting reduction in their
concentration is temporary, and the treatments may need to be repeated.
Clinical effects
depend on the underlying disease and cannot be guaranteed.
